trending Market Intelligence /marketintelligence/en/news-insights/trending/5WTFiwNaWP2vrnaq3A6Qxg2 content esgSubNav
In This List

Montagu in exclusive discussions to sell Dutch Ophthalmic Research Center

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet

Blog

Banking Essentials Newsletter: January 11th Edition

Blog

Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback

Infographic

Infographic: The Big Picture 2023 Sustainability Outlook


Montagu in exclusive discussions to sell Dutch Ophthalmic Research Center

Montagu Private Equity LLP entered into exclusive talks to sell its portfolio company Dutch Ophthalmic Research Center International BV, or D.O.R.C., to Eurazeo SE.

Netherlands-headquartered D.O.R.C. manufactures ophthalmic surgery instruments and equipment.

The proposed deal, terms of which were not disclosed, will be submitted to the workers' council of the target company and is subject to clearance from competition and regulatory authorities.

HSBC and RBC Capital Markets are the joint sell-side financial advisers.